Granulocyte development, tissue recruitment, and function during allergic inflammation
Open Access
- 4 April 2023
- journal article
- review article
- Published by Wiley in European Journal of Immunology
- Vol. 53 (8) , e2249977
Abstract
Granulocytes provide a fast innate response to pathogens and allergens. In allergy and anti‐helminth immunity, epithelial cells of damaged barriers release alarmins like IL‐25, IL‐33, and thymic stromal lymphopoietin (TSLP) but also chemokines like CXCL1 or CCL11 to promote cell recruitment and inflammation. In addition, mast cells positioned at barrier tissue sites also quickly release mediators upon specifically sensing antigens through IgE bound to FcεR1 on their surface. Released mediators induce the recruitment of different granulocytes in a timely ordered manner. First, neutrophils extravasate from the blood vasculature to the side of alarmin release and promote a potent inflammatory response. Alarmins and activated mast cells further promote activation of ILC2s and recruitment of basophils and eosinophils, which inhibit neutrophil recruitment and enhance tissue type 2 immunity. In addition to their potent pro‐inflammatory effector functions, granulocytes can also contribute to termination and resolution of inflammation. Here, we summarize the development and tissue recruitment of granulocyte subsets, and describe general effector functions and aspects of their increasingly appreciated role in limiting tissue damage. We further discuss targeting approaches for therapeutic interventions in allergic disorders.Keywords
This publication has 76 references indexed in Scilit:
- Mouse Basophils Reside in Extracellular Matrix-Enriched Bone Marrow Niches Which Control Their MotilityPLOS ONE, 2013
- Neutrophils Recruited to Sites of Infection Protect from Virus Challenge by Releasing Neutrophil Extracellular TrapsCell Host & Microbe, 2013
- Eosinophil recruitment and activation: the role of lipid mediatorsFrontiers in Pharmacology, 2013
- IL-4 Engagement of the Type I IL-4 Receptor Complex Enhances Mouse Eosinophil Migration to Eotaxin-1 In VitroPLOS ONE, 2012
- Retnla (Relmα/Fizz1) Suppresses Helminth-Induced Th2-Type ImmunityPLOS Pathogens, 2009
- Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lungJournal of Experimental Medicine, 2009
- Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthmaJournal of Leukocyte Biology, 2007
- Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophilsBlood, 2007
- No Effect of Anti-Interleukin-5 Therapy (Mepolizumab) on the Atopy Patch Test in Atopic Dermatitis PatientsInternational Archives of Allergy and Immunology, 2006
- INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in BiologyAnnual Review of Immunology, 1998